Oncology Drugs Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy (Biologic Therapy)
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oncology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Drugs Market Perspective (2017-2028)
2.2 Oncology Drugs Growth Trends by Region
2.2.1 Oncology Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oncology Drugs Historic Market Size by Region (2017-2022)
2.2.3 Oncology Drugs Forecasted Market Size by Region (2023-2028)
2.3 Oncology Drugs Market Dynamics
2.3.1 Oncology Drugs Industry Trends
2.3.2 Oncology Drugs Market Drivers
2.3.3 Oncology Drugs Market Challenges
2.3.4 Oncology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Drugs Players by Revenue
3.1.1 Global Top Oncology Drugs Players by Revenue (2017-2022)
3.1.2 Global Oncology Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Drugs Revenue
3.4 Global Oncology Drugs Market Concentration Ratio
3.4.1 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2021
3.5 Oncology Drugs Key Players Head office and Area Served
3.6 Key Players Oncology Drugs Product Solution and Service
3.7 Date of Enter into Oncology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Drugs Breakdown Data by Type
4.1 Global Oncology Drugs Historic Market Size by Type (2017-2022)
4.2 Global Oncology Drugs Forecasted Market Size by Type (2023-2028)
5 Oncology Drugs Breakdown Data by Application
5.1 Global Oncology Drugs Historic Market Size by Application (2017-2022)
5.2 Global Oncology Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oncology Drugs Market Size (2017-2028)
6.2 North America Oncology Drugs Market Size by Type
6.2.1 North America Oncology Drugs Market Size by Type (2017-2022)
6.2.2 North America Oncology Drugs Market Size by Type (2023-2028)
6.2.3 North America Oncology Drugs Market Share by Type (2017-2028)
6.3 North America Oncology Drugs Market Size by Application
6.3.1 North America Oncology Drugs Market Size by Application (2017-2022)
6.3.2 North America Oncology Drugs Market Size by Application (2023-2028)
6.3.3 North America Oncology Drugs Market Share by Application (2017-2028)
6.4 North America Oncology Drugs Market Size by Country
6.4.1 North America Oncology Drugs Market Size by Country (2017-2022)
6.4.2 North America Oncology Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Oncology Drugs Market Size (2017-2028)
7.2 Europe Oncology Drugs Market Size by Type
7.2.1 Europe Oncology Drugs Market Size by Type (2017-2022)
7.2.2 Europe Oncology Drugs Market Size by Type (2023-2028)
7.2.3 Europe Oncology Drugs Market Share by Type (2017-2028)
7.3 Europe Oncology Drugs Market Size by Application
7.3.1 Europe Oncology Drugs Market Size by Application (2017-2022)
7.3.2 Europe Oncology Drugs Market Size by Application (2023-2028)
7.3.3 Europe Oncology Drugs Market Share by Application (2017-2028)
7.4 Europe Oncology Drugs Market Size by Country
7.4.1 Europe Oncology Drugs Market Size by Country (2017-2022)
7.4.2 Europe Oncology Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Drugs Market Size (2017-2028)
8.2 Asia-Pacific Oncology Drugs Market Size by Type
8.2.1 Asia-Pacific Oncology Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oncology Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oncology Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Oncology Drugs Market Size by Application
8.3.1 Asia-Pacific Oncology Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oncology Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oncology Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Oncology Drugs Market Size by Region
8.4.1 Asia-Pacific Oncology Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oncology Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Drugs Market Size (2017-2028)
9.2 Latin America Oncology Drugs Market Size by Type
9.2.1 Latin America Oncology Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Oncology Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Oncology Drugs Market Share by Type (2017-2028)
9.3 Latin America Oncology Drugs Market Size by Application
9.3.1 Latin America Oncology Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Oncology Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Oncology Drugs Market Share by Application (2017-2028)
9.4 Latin America Oncology Drugs Market Size by Country
9.4.1 Latin America Oncology Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Oncology Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Drugs Market Size (2017-2028)
10.2 Middle East & Africa Oncology Drugs Market Size by Type
10.2.1 Middle East & Africa Oncology Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oncology Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oncology Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Oncology Drugs Market Size by Application
10.3.1 Middle East & Africa Oncology Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oncology Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oncology Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Oncology Drugs Market Size by Country
10.4.1 Middle East & Africa Oncology Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oncology Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Oncology Drugs Introduction
11.1.4 Roche Revenue in Oncology Drugs Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Oncology Drugs Introduction
11.2.4 Celgene Revenue in Oncology Drugs Business (2017-2022)
11.2.5 Celgene Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Oncology Drugs Introduction
11.3.4 Novartis Revenue in Oncology Drugs Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Oncology Drugs Introduction
11.4.4 Bristol-Myers Squibb Revenue in Oncology Drugs Business (2017-2022)
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Oncology Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Oncology Drugs Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Oncology Drugs Introduction
11.6.4 Merck & Co. Revenue in Oncology Drugs Business (2017-2022)
11.6.5 Merck & Co. Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Oncology Drugs Introduction
11.7.4 AstraZeneca Revenue in Oncology Drugs Business (2017-2022)
11.7.5 AstraZeneca Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Oncology Drugs Introduction
11.8.4 Pfizer Revenue in Oncology Drugs Business (2017-2022)
11.8.5 Pfizer Recent Developments
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Oncology Drugs Introduction
11.9.4 Amgen Revenue in Oncology Drugs Business (2017-2022)
11.9.5 Amgen Recent Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Oncology Drugs Introduction
11.10.4 Eli Lilly Revenue in Oncology Drugs Business (2017-2022)
11.10.5 Eli Lilly Recent Developments
11.11 AbbVie
11.11.1 AbbVie Company Details
11.11.2 AbbVie Business Overview
11.11.3 AbbVie Oncology Drugs Introduction
11.11.4 AbbVie Revenue in Oncology Drugs Business (2017-2022)
11.11.5 AbbVie Recent Developments
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Oncology Drugs Introduction
11.12.4 Takeda Revenue in Oncology Drugs Business (2017-2022)
11.12.5 Takeda Recent Developments
11.13 Astellas
11.13.1 Astellas Company Details
11.13.2 Astellas Business Overview
11.13.3 Astellas Oncology Drugs Introduction
11.13.4 Astellas Revenue in Oncology Drugs Business (2017-2022)
11.13.5 Astellas Recent Developments
11.14 Ipsen
11.14.1 Ipsen Company Details
11.14.2 Ipsen Business Overview
11.14.3 Ipsen Oncology Drugs Introduction
11.14.4 Ipsen Revenue in Oncology Drugs Business (2017-2022)
11.14.5 Ipsen Recent Developments
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Oncology Drugs Introduction
11.15.4 Sanofi Revenue in Oncology Drugs Business (2017-2022)
11.15.5 Sanofi Recent Developments
11.16 Bayer
11.16.1 Bayer Company Details
11.16.2 Bayer Business Overview
11.16.3 Bayer Oncology Drugs Introduction
11.16.4 Bayer Revenue in Oncology Drugs Business (2017-2022)
11.16.5 Bayer Recent Developments
11.17 Biogen Idec
11.17.1 Biogen Idec Company Details
11.17.2 Biogen Idec Business Overview
11.17.3 Biogen Idec Oncology Drugs Introduction
11.17.4 Biogen Idec Revenue in Oncology Drugs Business (2017-2022)
11.17.5 Biogen Idec Recent Developments
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Oncology Drugs Introduction
11.18.4 Teva Revenue in Oncology Drugs Business (2017-2022)
11.18.5 Teva Recent Developments
11.19 Otsuka
11.19.1 Otsuka Company Details
11.19.2 Otsuka Business Overview
11.19.3 Otsuka Oncology Drugs Introduction
11.19.4 Otsuka Revenue in Oncology Drugs Business (2017-2022)
11.19.5 Otsuka Recent Developments
11.20 Eisai
11.20.1 Eisai Company Details
11.20.2 Eisai Business Overview
11.20.3 Eisai Oncology Drugs Introduction
11.20.4 Eisai Revenue in Oncology Drugs Business (2017-2022)
11.20.5 Eisai Recent Developments
11.21 Merck KGaA
11.21.1 Merck KGaA Company Details
11.21.2 Merck KGaA Business Overview
11.21.3 Merck KGaA Oncology Drugs Introduction
11.21.4 Merck KGaA Revenue in Oncology Drugs Business (2017-2022)
11.21.5 Merck KGaA Recent Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Details
11.22.2 Gilead Sciences Business Overview
11.22.3 Gilead Sciences Oncology Drugs Introduction
11.22.4 Gilead Sciences Revenue in Oncology Drugs Business (2017-2022)
11.22.5 Gilead Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oncology Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Immunotherapy (Biologic Therapy)
Table 5. Key Players of Hormonal Therapy
Table 6. Key Players of Others
Table 7. Global Oncology Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Oncology Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Oncology Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Oncology Drugs Market Share by Region (2017-2022)
Table 11. Global Oncology Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Oncology Drugs Market Share by Region (2023-2028)
Table 13. Oncology Drugs Market Trends
Table 14. Oncology Drugs Market Drivers
Table 15. Oncology Drugs Market Challenges
Table 16. Oncology Drugs Market Restraints
Table 17. Global Oncology Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Oncology Drugs Revenue Share by Players (2017-2022)
Table 19. Global Top Oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2021)
Table 20. Ranking of Global Top Oncology Drugs Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Oncology Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncology Drugs Product Solution and Service
Table 24. Date of Enter into Oncology Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Oncology Drugs Revenue Market Share by Type (2017-2022)
Table 28. Global Oncology Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Oncology Drugs Revenue Market Share by Type (2023-2028)
Table 30. Global Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Oncology Drugs Revenue Share by Application (2017-2022)
Table 32. Global Oncology Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Oncology Drugs Revenue Share by Application (2023-2028)
Table 34. North America Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Oncology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Oncology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Oncology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Oncology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Oncology Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Oncology Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Oncology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Oncology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Oncology Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Oncology Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Oncology Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Oncology Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Oncology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Oncology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Oncology Drugs Product
Table 67. Roche Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 68. Roche Recent Developments
Table 69. Celgene Company Details
Table 70. Celgene Business Overview
Table 71. Celgene Oncology Drugs Product
Table 72. Celgene Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 73. Celgene Recent Developments
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Oncology Drugs Product
Table 77. Novartis Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 78. Novartis Recent Developments
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Oncology Drugs Product
Table 82. Bristol-Myers Squibb Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Developments
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Oncology Drugs Product
Table 87. Johnson & Johnson Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 88. Johnson & Johnson Recent Developments
Table 89. Merck & Co. Company Details
Table 90. Merck & Co. Business Overview
Table 91. Merck & Co. Oncology Drugs Product
Table 92. Merck & Co. Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 93. Merck & Co. Recent Developments
Table 94. AstraZeneca Company Details
Table 95. AstraZeneca Business Overview
Table 96. AstraZeneca Oncology Drugs Product
Table 97. AstraZeneca Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 98. AstraZeneca Recent Developments
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Oncology Drugs Product
Table 102. Pfizer Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 103. Pfizer Recent Developments
Table 104. Amgen Company Details
Table 105. Amgen Business Overview
Table 106. Amgen Oncology Drugs Product
Table 107. Amgen Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 108. Amgen Recent Developments
Table 109. Eli Lilly Company Details
Table 110. Eli Lilly Business Overview
Table 111. Eli Lilly Oncology Drugs Product
Table 112. Eli Lilly Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 113. Eli Lilly Recent Developments
Table 114. AbbVie Company Details
Table 115. AbbVie Business Overview
Table 116. AbbVie Oncology Drugs Product
Table 117. AbbVie Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 118. AbbVie Recent Developments
Table 119. Takeda Company Details
Table 120. Takeda Business Overview
Table 121. Takeda Oncology Drugs Product
Table 122. Takeda Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 123. Takeda Recent Developments
Table 124. Astellas Company Details
Table 125. Astellas Business Overview
Table 126. Astellas Oncology Drugs Product
Table 127. Astellas Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 128. Astellas Recent Developments
Table 129. Ipsen Company Details
Table 130. Ipsen Business Overview
Table 131. Ipsen Oncology Drugs Product
Table 132. Ipsen Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 133. Ipsen Recent Developments
Table 134. Sanofi Company Details
Table 135. Sanofi Business Overview
Table 136. Sanofi Oncology Drugs Product
Table 137. Sanofi Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 138. Sanofi Recent Developments
Table 139. Bayer Company Details
Table 140. Bayer Business Overview
Table 141. Bayer Oncology Drugs Product
Table 142. Bayer Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 143. Bayer Recent Developments
Table 144. Biogen Idec Company Details
Table 145. Biogen Idec Business Overview
Table 146. Biogen Idec Oncology Drugs Product
Table 147. Biogen Idec Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 148. Biogen Idec Recent Developments
Table 149. Teva Company Details
Table 150. Teva Business Overview
Table 151. Teva Oncology Drugs Product
Table 152. Teva Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 153. Teva Recent Developments
Table 154. Otsuka Company Details
Table 155. Otsuka Business Overview
Table 156. Otsuka Oncology Drugs Product
Table 157. Otsuka Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 158. Otsuka Recent Developments
Table 159. Eisai Company Details
Table 160. Eisai Business Overview
Table 161. Eisai Oncology Drugs Product
Table 162. Eisai Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 163. Eisai Recent Developments
Table 164. Merck KGaA Company Details
Table 165. Merck KGaA Business Overview
Table 166. Merck KGaA Oncology Drugs Product
Table 167. Merck KGaA Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 168. Merck KGaA Recent Developments
Table 169. Gilead Sciences Company Details
Table 170. Gilead Sciences Business Overview
Table 171. Gilead Sciences Oncology Drugs Product
Table 172. Gilead Sciences Revenue in Oncology Drugs Business (2017-2022) & (US$ Million)
Table 173. Gilead Sciences Recent Developments
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Drugs Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Immunotherapy (Biologic Therapy) Features
Figure 5. Hormonal Therapy Features
Figure 6. Others Features
Figure 7. Global Oncology Drugs Market Share by Application: 2021 VS 2028
Figure 8. Blood Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Gastrointestinal Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Respiratory or Lung Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Oncology Drugs Report Years Considered
Figure 15. Global Oncology Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Oncology Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Oncology Drugs Market Share by Region: 2021 VS 2028
Figure 18. Global Oncology Drugs Market Share by Players in 2021
Figure 19. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drugs as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Oncology Drugs Revenue in 2021
Figure 21. North America Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Oncology Drugs Market Size Market Share by Type (2017-2028)
Figure 23. North America Oncology Drugs Market Size Market Share by Application (2017-2028)
Figure 24. North America Oncology Drugs Market Size Share by Country (2017-2028)
Figure 25. United States Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Oncology Drugs Market Size Market Share by Type (2017-2028)
Figure 29. Europe Oncology Drugs Market Size Market Share by Application (2017-2028)
Figure 30. Europe Oncology Drugs Market Size Share by Country (2017-2028)
Figure 31. Germany Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Oncology Drugs Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Oncology Drugs Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Oncology Drugs Market Size Share by Region (2017-2028)
Figure 41. China Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Latin America Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Oncology Drugs Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Oncology Drugs Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Oncology Drugs Market Size Share by Country (2017-2028)
Figure 51. Mexico Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Oncology Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Oncology Drugs Market Size Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Oncology Drugs Market Size Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Oncology Drugs Market Size Share by Country (2017-2028)
Figure 57. Turkey Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. UAE Oncology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 61. Celgene Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 62. Novartis Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 64. Johnson & Johnson Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 65. Merck & Co. Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 66. AstraZeneca Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 67. Pfizer Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 68. Amgen Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 69. Eli Lilly Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 70. AbbVie Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 71. Takeda Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 72. Astellas Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 73. Ipsen Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 74. Sanofi Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 75. Bayer Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 76. Biogen Idec Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 77. Teva Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 78. Otsuka Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 79. Eisai Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 80. Merck KGaA Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 81. Gilead Sciences Revenue Growth Rate in Oncology Drugs Business (2017-2022)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
Industry Market Size
